Document Classification

Section Type: RESULTS

Text: At 10 years, the LTAD + RT group showed significant improvement over the STAD + RT group for all end points except overall survival : disease-free survival (13. 2 % v 22. 5 % ; P <. 0001), disease-specific survival (83. 9 % v 88. 7 % ; P =. 0042), local progression (22. 2 % v 12. 3 % ; P <. 0001), distant metastasis (22. 8 % v 14. 8 % ; P <. 0001), biochemical failure (68. 1 % v 51. 9 % ; P < or =. 0001), and overall survival (51. 6 % v 53. 9 %, P =. 36).